1. Home
  2. FPH vs ENTA Comparison

FPH vs ENTA Comparison

Compare FPH & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Five Point Holdings LLC

FPH

Five Point Holdings LLC

HOLD

Current Price

$4.84

Market Cap

354.2M

Sector

Finance

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$12.74

Market Cap

374.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FPH
ENTA
Founded
2009
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
354.2M
374.6M
IPO Year
2013
2012

Fundamental Metrics

Financial Performance
Metric
FPH
ENTA
Price
$4.84
$12.74
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$20.40
AVG Volume (30 Days)
183.4K
140.5K
Earning Date
04-23-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.93
EPS
N/A
N/A
Revenue
$110,020,000.00
$102,814,000.00
Revenue This Year
N/A
$7.76
Revenue Next Year
N/A
N/A
P/E Ratio
$11.40
N/A
Revenue Growth
N/A
16.48
52 Week Low
$4.58
$4.09
52 Week High
$6.64
$17.15

Technical Indicators

Market Signals
Indicator
FPH
ENTA
Relative Strength Index (RSI) 30.56 44.35
Support Level N/A $12.09
Resistance Level $5.71 $15.52
Average True Range (ATR) 0.15 0.70
MACD -0.03 -0.13
Stochastic Oscillator 9.97 28.70

Price Performance

Historical Comparison
FPH
ENTA

About FPH Five Point Holdings LLC

Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational, and recreational elements, as well as civic areas, parks, and open spaces. Its four reportable segments are Valencia, San Francisco, Great Park, and Hearthstone. It derives the majority of revenue from the Great Park segment, which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: